The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis

Inflammation Research

Volumn 55, Issue 4, 2006, Pages 168-175

  Jackson, J K ^a   Higo, T ^a   Hunter, W L ^b   Burt, H M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Angiotech Pharmaceuticals Inc   (Canada)

Author keywords

Antioxidants; Crystal induced Arthritis; Curcumin; Quercetin; Rheumatoid Arthritis

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; COLLAGENASE; CURCUMIN; IMMUNOSUPPRESSIVE AGENT; LUMINOL; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; QUERCETIN; STROMELYSIN; URATE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CARTILAGE CELL; CATTLE; CELL ASSAY; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CHEMOLUMINESCENCE; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; CRYSTAL; DRUG MECHANISM; GOUT; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; MTS ASSAY; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; RABBIT; SYNOVIOCYTE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; ARTHRITIS; CATTLE; CELL LINE; CELL PROLIFERATION; CHEMILUMINESCENT MEASUREMENTS; CHONDROCYTES; COLLAGENASES; CURCUMIN; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 3; NEUTROPHILS; PROTEOGLYCANS; QUERCETIN; RABBITS;

EID: 33745598838     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-0067-z     Document Type: Article

References (42)

1. th edition). Philadelphia: Lippincott, Williams and Wilkins. 2005.
2. Araujo CC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 2001; 95: 723-8.
3. Miquel J, Bernd A, Sempere JM, Diaz-Alperi J, Ramirez A. The curcuma antioxidants: pharmacological effects and prospect for future clinical use: A review. Arch Gerontol Geriat 2002; 34: 37-46.
4. Sato M, Miyazaki T, Kambe F, Maeda K, Seo H. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 1997; 24: 1680-4.
5. Gabor M. Anti-inflammatory and antiallergic properties of flavenoids. Prog Clin Biol Res 1986; 213: 471-80.
6. Bobrovnikova-Marjon EV, Marjon PL, Barbash O, Vander Jagt DL, Abcouwer SF. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activation protein-1. Cancer Res 2004; 64: 4858-69.
7. Witek-Zawada B, Koj A. Regulation of expression of stromyelysin-1 by proinflammatory cytokines in mouse brain astrocytes. J Physiol Pharmacol. 2003; 54: 489-96.
8. Kumar A, Dhawan S, Hardegen NJ, Aggarwal BB. Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem Pharmacol 1998; 55: 775-83.
9. Bosse WW, Kopp DE, Middleton EH. Flavenoid modulation of human neutrophil function. J Allergy Clin. Immunol 1984; 23: 801-6.
10. Kang TB, Liang NC. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Phamacol 1997; 54: 1013-8.
11. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A et al. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 1990; 260: 10-3.
12. Yoshida M, Yamamoto M, Nikaido T. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 1992; 52: 6676-81.
13. Singhal RL, Yeh YA, Prajda N, Sledge GW, Weber G. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun 1995; 208: 425-31.
14. Prusty BK, Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 2005; 113: 951-60.
15. Hahm ER, Gho YS, Park S, Park C, Kim KW, Yang CH. Synthetic curcumins analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochem Biophys Res Commun 2004; 321: 337-4.
16. Hui A, Min WX, Tang J. Cruz TF. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes. Arthritis Rheum 1998; 41: 869-76.
17. Hui A, Kulkarni GV, Hunter WL, McCulloch Ca, Cruz TF. Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes. Arthritis Rheum 1997; 40: 1073-84.
18. Jackson JK, Tudan C, Sahl B, Pelech SL, Burt HM. Calcium pyrophosphate dihydrate crystals activate MAP kinase in human neutrophils: inhibition of MAP kinase, oxidase activation and degranulation responses of neutrophils by taxol. Immunology 1997; 90: 502-10.
19. Brahn E, Tang C, Banquerigo ML. Regression of collagen-induced arthritis with taxol, a microtubule stabilizer. Arthritis Rheum 1994; 37: 839-45.
20. Liggins RT, Cruz T, Min W, Liang L, Hunter WL, Burt HM. Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits. Inflamm Res 2004; 53: 363-72.
21. Winternitz CI, Jackson JK, Oktaba AM, Burt HM. Development of a polymeric surgical paste formulation for taxol. Pharm Res 1995; 13: 368-75.
22. Burt HM, Kalkman PH, Maudlin D. Membranolytic effects of crystalline monosodium urate monohydrate. J Rheumatol. 1983; 10: 440-8.
23. Jackson JK, Burt HM, Oktaba AM, Hunter W, Scheid MP, Mouhajir F, Lauener RW, Shen Y, Salari H, Duronio V. The antineoplastic ether lipid, s-phosphonate, selectively induces apoptosis in human leukemic cells and exhibits antiangiogenic and apoptotic activity on the chorioallantoic membrane of the chick embryo. Cancer Chemother Pharmacol 1998; 41: 326-32.
24. Furness MS, Robinson TP, Ehlers T, Hubbard RB, Arbiser JL, Goldsmith DJ, et al. Antiangiogenic agents: studies on fumagillin and curcumin analogs. Curr Pharm Des 2005; 11: 357-73.
25. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 1998; 9: 305-12.
26. Philip S, Bulbule A, Kundu GC. Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediates activation and its role in cell motility and ECM invasion. Glycoconj J 2004; 21: 429-41.
27. Bachmeier BE, Iancu CM, Jochum M, Nerlich AG. Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev Anticancer Ther 2005; 5: 149-63.
28. Schulze-Tanzil G, Mobasheri A, Sendzik J, John T, Shakibaei M. Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1-beta-stimulated chondrocytes. Ann NY Acad Sci 2004; 1030: 578-86.
29. Liacini A, Sylvester J, Li WQ, Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 2002; 21: 251-62.
30. Liacini A, Sylvester J, Li WQ, Huang W, Dehnade F, Ahmad M, Zafarullah M. Induction of matrix metalloproteinase-13 gene expression by TNF-α is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res. 2003; 288: 208-17.
31. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000; 275: 444-50.
32. Madan B, Ghosh B. Diferuloylmethane inhibits neutrophil infiltration and improves survival of mice in high dose endotoxin shock. Shock 2003; 19: 91-6.
33. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 1993; 38: 113-9.
34. Flynn DL, Rafferty MF, Boctor AM. Inhibition of 5-hydroxy- eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 1986; 22: 357-60.
35. Limasset B, le Doucen C, Dore JC. Ojasoo T, Damon M. Crastes de Paul A. Effects of flavonoids on the release of reactive oxygen species by stimulated human neutrophils. Multivariate analysis by structural activity relationships (SAR). Biochem Pharmacol 1993; 46: 1257-71.
36. Tudan C, Jackson JK, Higo TT, Burt HM. The effect of inhibiting topoisomerase I and II on the anti-apoptotic response associated with pro-inflammatory crystals of calcium pyrophosphate dihydrate in human neutrophils. Inflamm Res 2003; 52: 8-17.
37. Tudan C, Jackson JK, Blanis L, Pelech SL, Burt HM. Inhibition of TNF-α-induced neutrophil apoptosis by crystals of calcium pyrophosphate dihydrate is mediated by the extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways upstream of caspase 3. J Immunol 2000; 165: 5798-806.
38. Tudan C, Fong D, Duronio V, Burt HM, Jackson JK. Inhibition of TNF-alpha and spontaneous apoptosis by crystals of calcium pyrophosphate dihydrate in neutrophils. J Rheumatol 2000; 27: 2463-72.
39. O'Dell JR. Methotrexate use in rheumatoid arthritis . Rheum. Dis Clin North Am. 1997; 23: 779-96.
40. Brouet I, Ohshima H. Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Ann Nutr Med 1994; 38: 349-58.
41. Banerjee M, Tripathi LM, Srivastava VML, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol 2003; 25: 213-24.
42. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Alternative Complementary Med 2003; 9: 161-8.